MedTrace Logo

Malaria Clinical Trials Center General Screening

NCT02119312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2101

Last updated 2020-09-14

No results posted yet for this study

Summary

The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.

Conditions

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • James G Kublin, MD · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2020-09-01
Completion
2020-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02119312 on ClinicalTrials.gov